EUVIMEDEUVIMED entdecken
Crossref

Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT)

Chloé Hardy, Anna Gosset, Léa Rouchou, Sandrine Frantz, Claude Hocke, Florence Tremollieres, Valérie Bernard

Maturitas · 2026-05 · 208 · 108923

DOI: 10.1016/j.maturitas.2026.108923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Maturitas, 2026-05. Verfasst von Chloé Hardy und 6 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Bordeaux, Department of Gynecology and Reproductive medicine, F-33000, Bordeaux, France. Hauptthemen laut MEDLINE: Practice Patterns, Physicians', Hot Flashes, Menopause, Estrogen Replacement Therapy. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Menopause Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study was performed to provide an updated overview of menopause management among French gynaecologists in 2025, with a focus on prescribing practices for menopausal hormone therapy (MHT), perceived barriers, and the use of alternative therapies. STUDY DESIGN This national, cross-sectional, anonymous online survey was conducted between March and June 2025. MAIN OUTCOME MEASURES The primary outcome was the proportion of respondents prescribing MHT as first-line therapy for moderate to severe vasomotor symptoms (VMS) in women without contraindications. The secondary outcomes were physicians' perceptions assessed using 0-10 scales, barriers to prescribing, and the use of alternative therapies. RESULTS In total, 440 questionnaires were analysed. Overall, 76.4% of physicians reported prescribing MHT as first-line treatment for VMS. The median rating of 'comfort with prescribing' was 8.0 (interquartile range 7.0-9.0), and perceived benefit was high (median 9.0, interquartile range 8.0-10.0). The most frequently reported barriers were patients' hesitancy (59.8%), physicians' concern regarding elevated risks of breast cancer and cardiovascular events (34.8% and 29.5%, respectively). Alternative therapies were commonly used, mainly in cases of contraindication to or refusal of MHT; dietary supplements (70.0%), acupuncture (39.0%), and phytoestrogens (37.0%) were the most frequently prescribed. Finally, 67% of respondents expressed interest in additional training on MHT. CONCLUSIONS Despite strong perceived benefits and a high level of comfort with prescribing, one in four gynaecologists does not systematically offer MHT as first-line therapy for moderate to severe VMS. A gap persists between guidelines and real-life menopause care. Patient hesitancy and risk perceptions underline the need for improved education and decision-support tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Patterns, Physicians'Hot FlashesMenopauseEstrogen Replacement TherapyAttitude of Health PersonnelHormone Replacement TherapyHumansFemaleFranceCross-Sectional StudiesMiddle AgedSurveys and QuestionnairesGynecologistsComplementary TherapiesAdult

Stichwörter der Autor:innen

Menopausal hormone therapyMenopauseMenopause managementVasomotor symptoms

Autor:innen und Institutionen

  • CHU de Bordeaux, Department of Gynecology and Reproductive medicine, F-33000, Bordeaux, France.
  • CHU de Toulouse, Department of Menopause, F-31000, Toulouse, France.
  • CHU de Bordeaux, Department of Gynecology and Reproductive medicine, F-33000, Bordeaux, France; Univ. Bordeaux, Bordeaux Institute in Oncology-BRIC-BioGo Team, INSERM U1312, F-33000, Bordeaux, France. Electronic address…

Förderung

  • Menopause Society

Zitieren

APA

Hardy, C., Gosset, A., Rouchou, L., Frantz, S., Hocke, C., Tremollieres, F., & Bernard, V. (2026). Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT). Maturitas, 208, 108923. https://doi.org/10.1016/j.maturitas.2026.108923

Vancouver

Hardy C, Gosset A, Rouchou L, Frantz S, Hocke C, Tremollieres F, et al. Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT). Maturitas. 2026;208:108923. doi:10.1016/j.maturitas.2026.108923

BibTeX
@article{Hardy2026,
  author = {Hardy, Chloé and Gosset, Anna and Rouchou, Léa and Frantz, Sandrine and Hocke, Claude and Tremollieres, Florence and Bernard, Valérie},
  title = {Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT)},
  journal = {Maturitas},
  year = {2026},
  volume = {208},
  pages = {108923},
  doi = {10.1016/j.maturitas.2026.108923}
}
Kostenlos starten →